Yellow fever and Japanese encephalitis vaccines: indications and complications
- 1 March 2005
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 19 (1) , 151-168
- https://doi.org/10.1016/j.idc.2004.11.004
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?Comparative Immunology, Microbiology and Infectious Diseases, 2004
- A Belgian Traveler Who Acquired Yellow Fever in The GambiaClinical Infectious Diseases, 2002
- Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.The American Journal of Tropical Medicine and Hygiene, 2002
- Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencingVaccine, 2001
- Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.The American Journal of Tropical Medicine and Hygiene, 1999
- Facing up to re-emergence of urban yellow fe verThe Lancet, 1999
- Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infectionJournal of Medical Virology, 1998
- Imported yellow fever in a United States citizen.Clinical Infectious Diseases, 1997
- Yellow Fever VaccinesBiologicals, 1997
- Jungle yellow fever in the central AmazonThe Lancet, 1996